Dr Reddys Laboratories has announced its fourth quarter results. The company's Q4 consolidated net profit was at Rs 103 crore versus 325.5 crore (US GAAP).
Its Q4 consolidated net sales were at Rs 1320 crore versus Rs 1557.3 crore(US GAAP).
The company's FY08 consolidated net profit stood at Rs 470 crore.
DRL Q4FY07 numbers included Zofran Exclusivity (Rs 270 crore).
No comments:
Post a Comment